Thora Majlund Kjærulff (Thora Majlund Kjaerulff)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Cross Sectional

Palliative Care

Acute Myocardial Infarction

Top Venues

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Thora Majlund Kjærulff, Kristine Bihrmann, Jens Soendergaard, Gunnar Hilmar Gislason, Mogens Lytken Larsen, Annette Kjaer Ersbøll
Association between travel distance and face-to-face consultations with general practitioners before an incident acute myocardial infarction: a nationwide register-based spatial epidemiological study. BMJ open 14 (1) (2024)
Thora Majlund Kjærulff, Kristine Bihrmann, Jens Soendergaard, Gunnar Hilmar Gislason, Mogens Lytken Larsen, Annette Kjaer Ersbøll
Association between travel distance and face-to-face consultations with general practitioners before an incident acute myocardial infarction: a nationwide register-based spatial epidemiological study. BMJ open 14 (1) (2024)
Thora Majlund Kjærulff, Kristine Bihrmann, Jens Soendergaard, Gunnar Hilmar Gislason, Mogens Lytken Larsen, Annette Kjaer Ersbøll
Association between travel distance and face-to-face consultations with general practitioners before an incident acute myocardial infarction: a nationwide register-based spatial epidemiological study. BMJ open 14 (1) (2024)
Thora Majlund Kjærulff, Kristine Bihrmann, Jens Soendergaard, Gunnar Hilmar Gislason, Mogens Lytken Larsen, Annette Kjaer Ersbøll
Association between travel distance and face-to-face consultations with general practitioners before an incident acute myocardial infarction: a nationwide register-based spatial epidemiological study. BMJ open 14 (1) (2024)
Thora Majlund Kjærulff, Annette Kjaer Ersbøll, Eero Pukkala, Kristian Bolin, Anders Green, Martha Emneus, Klaus Brasso, Peter Iversen, Lau Caspar Thygesen
Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden. Pharmacoepidemiology and drug safety 29 (4) (2020)